valproic acid has been researched along with sodium butyrate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bitterman, PB; Huo, Y; Mahmud, SA; Slungaard, A; Wang, J | 1 |
| Bora-Tatar, G; Dalkara, S; Dayangaç-Erden, D; Demir, AS; Erdem-Yurter, H; Yelekçi, K | 1 |
| Qiu, X; Tan, Y; Wan, L; Wang, H; Yang, L; Yang, Z; Zhu, L | 1 |
1 review(s) available for valproic acid and sodium butyrate
| Article | Year |
|---|---|
From natural products to HDAC inhibitors: An overview of drug discovery and design strategy.
Topics: Biological Products; Drug Design; Drug Discovery; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Molecular Structure | 2021 |
1 trial(s) available for valproic acid and sodium butyrate
| Article | Year |
|---|---|
Histone deacetylase inhibitors suppress TF-kappaB-dependent agonist-driven tissue factor expression in endothelial cells and monocytes.
Topics: Acetylation; Cells, Cultured; E-Selectin; Endothelial Cells; Enzyme Induction; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Intercellular Adhesion Molecule-1; Interleukin-1beta; Lipopolysaccharides; Monocytes; NF-kappa B; Protein Binding; Response Elements; RNA, Messenger; RNA, Small Interfering; Thromboplastin; Thrombosis; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2007 |
1 other study(ies) available for valproic acid and sodium butyrate
| Article | Year |
|---|---|
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.
Topics: Caffeic Acids; Carboxylic Acids; Catalytic Domain; Chlorogenic Acid; Curcumin; Enzyme Inhibitors; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Models, Molecular; Molecular Structure; Protein Binding | 2009 |